BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34196951)

  • 1. Characterization of dopamine D
    Egusquiza I; Munarriz-Cuezva E; Segarra R; González-Maeso J; Callado LF; Meana JJ; Diez-Alarcia R
    Pharmacol Rep; 2021 Aug; 73(4):1136-1146. PubMed ID: 34196951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
    Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical modulation of agonist-induced [35s]GTPgammaS binding: implications for coexistence of multiple functional conformations of dopamine D1-like receptors.
    Panchalingam S; Undie AS
    J Recept Signal Transduct Res; 2005; 25(2):125-46. PubMed ID: 16149770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic cocaine dampens dopamine signaling during cocaine intoxication and unbalances D1 over D2 receptor signaling.
    Park K; Volkow ND; Pan Y; Du C
    J Neurosci; 2013 Oct; 33(40):15827-36. PubMed ID: 24089490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment.
    Urigüen L; García-Fuster MJ; Callado LF; Morentin B; La Harpe R; Casadó V; Lluis C; Franco R; García-Sevilla JA; Meana JJ
    Psychopharmacology (Berl); 2009 Oct; 206(2):313-24. PubMed ID: 19652957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
    Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5'(gamma-thiotriphosphate) ([35S]GTPgammaS) binding in rat striatal membranes.
    Rinken A; Finnman UB; Fuxe K
    Biochem Pharmacol; 1999 Jan; 57(2):155-62. PubMed ID: 9890563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and pharmacological characterization of receptor-mediated G
    Odagaki Y; Kinoshita M; Ota T; Meana JJ; Callado LF; García-Sevilla JA
    Basic Clin Pharmacol Toxicol; 2019 Jun; 124(6):649-659. PubMed ID: 30507034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the human D1 and D2 dopamine receptor signaling complexes.
    Zhuang Y; Xu P; Mao C; Wang L; Krumm B; Zhou XE; Huang S; Liu H; Cheng X; Huang XP; Shen DD; Xu T; Liu YF; Wang Y; Guo J; Jiang Y; Jiang H; Melcher K; Roth BL; Zhang Y; Zhang C; Xu HE
    Cell; 2021 Feb; 184(4):931-942.e18. PubMed ID: 33571431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of receptor-mediated [35S]GTPgammaS binding to cortical membranes from postmortem human brain.
    González-Maeso J; Rodríguez-Puertas R; Gabilondo AM; Meana JJ
    Eur J Pharmacol; 2000 Feb; 390(1-2):25-36. PubMed ID: 10708703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats.
    Perreault ML; Hasbi A; Alijaniaram M; O'Dowd BF; George SR
    Neuroscience; 2012 Dec; 225():130-9. PubMed ID: 22986162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction pathway activity compensates dopamine D₂/D₃ receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [³H]raclopride and [³⁵S]GTPγS.
    Farkas S; Nagy K; Jia Z; Hortobágyi T; Varrone A; Halldin C; Csiba L; Gulyás B
    Brain Res; 2012 May; 1453():56-63. PubMed ID: 22480734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional coupling between adenosine A
    Odagaki Y; Kinoshita M; Ota T; Meana JJ; Callado LF; Matsuoka I; García-Sevilla JA
    Purinergic Signal; 2018 Jun; 14(2):177-190. PubMed ID: 29492786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-induced [35S]GTPgammaS binding in the membranes of Spodoptera frugiperda insect cells expressing the human D3 dopamine receptor.
    Pregenzer JF; Alberts GL; Im WB
    Neurosci Lett; 1997 Apr; 226(2):91-4. PubMed ID: 9159497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT
    García-Bea A; Miranda-Azpiazu P; Muguruza C; Marmolejo-Martinez-Artesero S; Diez-Alarcia R; Gabilondo AM; Callado LF; Morentin B; González-Maeso J; Meana JJ
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1453-1463. PubMed ID: 31734018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
    Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
    Nature; 1997 Feb; 385(6617):634-6. PubMed ID: 9024661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.